Metamizole may decrease the antihypertensive activities of Bisoprolol. Dipivefrin may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Propacetamol may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide Mononitrate. Tacrine may increase the bradycardic activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Clemastine. The metabolism of Bisoprolol can be decreased when combined with Desipramine. Fentanyl may increase the bradycardic activities of Bisoprolol. The metabolism of Bisoprolol can be increased when combined with Rifabutin. The metabolism of Bisoprolol can be decreased when combined with Crizotinib. Bisoprolol may increase the hypotensive activities of Niguldipine. Ruxolitinib may increase the bradycardic activities of Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Cobicistat. Cyclothiazide may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Bisoprolol. Salicylic acid may decrease the antihypertensive activities of Bisoprolol. Teriflunomide may decrease the antihypertensive activities of Bisoprolol. Isoxicam may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Deserpidine. The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Sarilumab. Decamethonium may increase the bradycardic activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Nelfinavir. Naphazoline may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Phenylbutazone may decrease the antihypertensive activities of Bisoprolol. Balsalazide may decrease the antihypertensive activities of Bisoprolol. Tinoridine may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bisoprolol. Travoprost may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Nisoldipine is combined with Bisoprolol. Barbital may increase the hypotensive activities of Bisoprolol. E-6201 may decrease the antihypertensive activities of Bisoprolol. Semapimod may decrease the antihypertensive activities of Bisoprolol. Pirlindole may increase the hypotensive activities of Bisoprolol. Tranilast may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Bupropion. Piroxicam may decrease the antihypertensive activities of Bisoprolol. Tolfenamic Acid may decrease the antihypertensive activities of Bisoprolol. Tenoxicam may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Calfactant. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bumetanide. Bisoprolol may increase the orthostatic hypotensive activities of Bucindolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nadolol. Bisoprolol may increase the hypotensive activities of Vinpocetine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Epibatidine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Floctafenine. Bisoprolol may increase the hypotensive activities of Amifostine. The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Bisoprolol. Bisoprolol may increase the orthostatic hypotensive activities of Carvedilol. The risk or severity of adverse effects can be increased when Esmolol is combined with Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Penbutolol. The risk or severity of adverse effects can be increased when Enalapril is combined with Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Mitotane. The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol. Evening primrose oil may decrease the antihypertensive activities of Bisoprolol. Vardenafil may increase the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Mibefradil. Tizanidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Digoxin Immune Fab (Ovine). The serum concentration of Bisoprolol can be decreased when it is combined with Vemurafenib. The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Bisoprolol. Toloxatone may increase the hypotensive activities of Bisoprolol. Nabumetone may decrease the antihypertensive activities of Bisoprolol. Alimemazine may increase the hypotensive activities of Bisoprolol. Guanabenz may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Xylometazoline may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Bethanidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Fluphenazine may increase the hypotensive activities of Bisoprolol. Perazine may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Lobeline. Octamoxin may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Terbinafine. Lofexidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Methanesulfonyl Fluoride may increase the bradycardic activities of Bisoprolol. Paliperidone may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Zileuton may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Telaprevir. Oxyphenbutazone may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Rucaparib. Bisoprolol may increase the bradycardic activities of Midodrine. Bisoprolol may decrease the bronchodilatory activities of Bambuterol. The metabolism of Bisoprolol can be decreased when combined with Quinidine. Salsalate may decrease the antihypertensive activities of Bisoprolol. Castanospermine may decrease the antihypertensive activities of Bisoprolol. Indomethacin may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Spirapril. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Losartan. Bisoprolol may increase the hypotensive activities of Cryptenamine. The risk or severity of adverse effects can be increased when Triamterene is combined with Bisoprolol. Secobarbital may increase the hypotensive activities of Bisoprolol. Curcumin may decrease the antihypertensive activities of Bisoprolol. Disopyramide may increase the bradycardic activities of Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Etoperidone. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Diclofenamide. Molsidomine may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypoglycemic activities of Glipizide. Bisoprolol may increase the bradycardic activities of Lanreotide. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Perindopril. The serum concentration of Bisoprolol can be increased when it is combined with Indalpine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Methyldopa. Bisoprolol may increase the hypotensive activities of Tolazoline. The serum concentration of Bisoprolol can be increased when it is combined with Zimelidine. Gallamine Triethiodide may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nicardipine. The serum concentration of Bisoprolol can be decreased when it is combined with Tocilizumab. Carprofen may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Bupranolol. Bisoprolol may increase the bradycardic activities of Fingolimod. Acepromazine may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pilocarpine. Hexobarbital may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Omapatrilat. Ketanserin may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Acebutolol. Bisoprolol may decrease the bronchodilatory activities of Isoprenaline. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Metipranolol. The risk or severity of adverse effects can be increased when Benazepril is combined with Bisoprolol. Iproniazid may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Furosemide. Bisoprolol may increase the hypoglycemic activities of Glisoxepide. The metabolism of Bisoprolol can be decreased when combined with Hydroxychloroquine. The risk or severity of adverse effects can be increased when Carbetocin is combined with Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Dapagliflozin. Bisoprolol may increase the hypotensive activities of Ferulic acid. The risk or severity of adverse effects can be increased when Fosinopril is combined with Bisoprolol. Udenafil may increase the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Obinutuzumab. Bisoprolol may increase the hypotensive activities of Enalaprilat. Bisoprolol may decrease the bronchodilatory activities of Dyphylline. Bucillamine may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Pramipexole is combined with Bisoprolol.